The Global Blood Gas and Electrolyte Analyzers Market was worth USD 3.75 Billion in 2020 and is projected to attain USD 6.38 Billion by 2027, developing at a CAGR of 7% from 2021 to 2027. A boom withinside the number of sufferers brought about extra blood sample testing, and therefore Blood Gas and Electrolyte Analyzers activity have increased. Blood Gas, increasing technological improvements, research activities, & the healthcare zone have helped in the market boom. Government funding is likewise promoting the boom of the Blood Gas and Electrolyte Analyzers Market. The market record presents a holistic assessment of the market.
A blood gas and electrolyte analyzer is required to measure blood gas, electrolytes, pH, and some metabolites in entire blood specimens. Blood gas analyzers use electrodes, while electrolyte analyzers use ion-selective electrode (ISE) methodology. Blood gas and electrolyte analyzers use modern and superior technology. They offer brief and correct consequences for blood gases, ionized calcium, acid-base balance, electrolytes, BUN, glucose, and lactate. Also, it requires minimal maintenance. Blood Gas and Electrolyte Analyzers offer lab-quality consequences with zero standby cost. Also, they permit a wide operating temperature range to meet the needs of less warm environments.
Increasing incidence of chronic sicknesses leading to diabetes and other cardiovascular disease is a major aspect of the Blood Gas and Electrolyte Analyzer Market boom at some point in the forecast length 2021-2026. According to the World Health Organization, approx 422 million human beings worldwide have diabetes, especially in low and middle-profit nations, and 1.6 million deaths are immediately attributed to diabetes every year. Similarly, an expected 17.9 million lives are lost every year because of cardiovascular diseases making it the primary purpose of losing life globally. Growing diabetes and cardiovascular sufferers is leading to the growth in diagnosis and thereby propelling the market.
Technological Advancements in Blood Gas and Electrolyte Analyzer are driving its market forecast for 2021-2027. Test parameters included in these technologically advanced analyzers encompass blood gas, electrolytes, metabolites, co-oximetry, and pleural fluid pH. For example, NY-based Siemens Healthcare Diagnostic gives the RAPIDPoint 500 Blood Gas System, which offers important values in approximately 1 minute with a complete test menu from a single sample, permitting clinicians to recognize improved patient care. Furthermore, this analyzer device can also be set up to record key ventilator settings in critical care, such as flow, respiratory rate, non-stop positive airway strain, positive end-expiratory pressure, and Allen test, thereby contributing to the increase of its market.
The Blood Gas and Electrolyte Analyzer market were operating at a smooth phase in the pre covid era because of the Increasing technological improvements and research activities & the healthcare zone and day by day increasing government funding.
The COVID-19 pandemic has been validated to have pretty destructive outcomes for the global market, as increasingly more human beings have followed the stay-at-home policy, which has decreased the call for top products. In addition, governments throughout the globe have taken measures that include enforcing lockdowns, which has affected the rise of the blood gas and electrolyte analyzer market.
The Blood Gas and electrolyte analyzer market is expected to run strong in the post covid era because of the increasing demand for blood gas and electrolyte analyzer because the business enterprise sources are getting decentralized and growing in volume. The developing investments and tendencies withinside the market and increasing occurrence of chronic diseases withinside the place is anticipated to create possibilities for the market.
Based on modality, the market is divided into portable and benchtop. The portable devices are easy to use, handle, and have minimal upkeep requirements, allowing for their better adoption fee. There are several companies which are investing in the improvement and advertising of these products. Though there’s the threshold for the portable devices over the conventional devices, the concerns and challenges arise while being operated through the non-laboratory group of workers inclusive of nurses and physicians, which often restricts the extent of results being obtained. In emergency and critical care settings, the doctors/physicians and laboratorians must construct upon the synergistic efforts towards using transportable gadgets in POCT and conventional laboratory settings. With that, the positives and benefits of using such devices are more, which drives the adoption fee of these products in the market over the forecast period.
The market is divided into Blood Gas Analyzer, Electrolyte Analyzer, Combined Analyzer and other products. Out of these, the blood gas analyzers section and electrolyte analyzers section is the top with a majority market share, covering about 45% of the total market. Electrolyte Analyzer and Blood Gas analyzer are leading the segment Blood gas, and electrolyte analyzers are used for testing diverse factors of diseases in the blood. They are a fundamental approach to figuring out diabetes, blood vessel hemorrhage, drug consumption, etc. This is especially due to the excessive incidence of chronic disorders across the globe. Advancements in technology and more progressive analyzers have led to convenient and easy-to-use devices.
Based on End-User, the market is divided into centralized laboratories, points of care, others. Point-of-Care is expected to witness the largest market share in 2020 and is projected to develop at a CAGR of 5.8% due to the growing demand for speedy diagnostic near-patient bed aspects and decreasing healthcare expenditure by averting lengthy hospital stays. Reduction in the length of health center stay is one of the primary blessings of a factor of care testing; the fast availability of the test result reduces the time to decide, thereby allowing more rapid screening, remedy or discharge. Increasing range of persistent illnesses and immediate patient care that is feasible due to factor of care testing, along with high speculation of the end-user for a secure opportunity because of the COVID-19, are the other major factors driving the Point-of-Care segment in Blood Gas and Electrolyte Analyzer Market all through the forecast period 2021-2027.
The global Virtualization Software market is analyzed throughout North America, Europe, Asia-Pacific, South America, and Middle East & Africa based on region. North America is anticipated to dominate this market in phrases of sales generated over the forecast period. The huge presence of domestic and global medical devices companies from each developed and emerging markets boost the demand and growth of analyzes in the country. The better network among the multispecialty hospitals with the insurance companies and medical device companies drives the significance of this market in the United States. For instance, in March 2020, Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer, used in critical care settings, received US Food and Drug Administration approval.
Furthermore, medical tourism also draws many sufferers from many nations to get higher healthcare centers within the region. The developing preference towards the point of care testing by each company and hospital fuels the region’s boom of the studied market. Europe is expected to follow subsequent market size due to the significant presence of scientific tool businesses and the vintage age populace throughout the region.
The companies in this market have advanced in providing analyzers with display monitors to screen the sufferers earlier than electronically, shifting them for everlasting reports inside statistics control systems. Some of the top gamers lively on this market include Abbott laboratories, F Hoffman La Roche Ltd, Siemens Healthineers, Medica Corporation, and Danaher Corporation.
1) In March 2020, the U.S.FDA accredited Siemens Healthineers’s essential care testing solution, the RAPIDPoint 500e blood gas analyzer.
2) In March 2020, Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer, utilized in important care settings, has acquired US Food and Drug Administration approval.
3) In May 2020, Rochehad introduced that it acquired the CE mark for Roche v-TAC, a virtual diagnostic solution that lets clinicians reap consequences for arterial blood gas values of sufferers with respiratory or metabolic abnormalities. The Roche v-TAC is handy to use and is less invasive than the usage of a virtual algorithm.
|Market Size Value in 2020||USD 3.75 billion|
|The revenue forecast in 2027||USD 6.38 Billion|
|Growth Rate||CAGR Of 7% from 2021-2027|
|Quantitative Units||Revenue in USD Million, Volume in a million square meters.|
|Region covered||North America, Europe, South America, Asia-Pacific, and Middle East & Africa|
|Key companies Profiled||Abbott laboratories, F Hoffman La Roche Ltd, Siemens Healthineers, Medica Corporation, Danaher Corporation, etc.|
By Modality Type
By Product Type
Portable Blood gas is the leading segment in the Blood Gas and electrolyte analyzer market. The portable devices are easy to use, handle, and have minimal upkeep requirements, allowing for their better adoption fee. There are several companies which are investing in the improvement and advertising of these products.
North America is anticipated to dominate this market in sales generated over the forecast period. The huge presence of domestic and global medical devices companies from each developed and emerging markets boost the demand and growth of analyzes in the country.
Abbott laboratories, F Hoffman La Roche Ltd, Siemens Healthineers, Medica Corporation, Danaher Corporation, etc.
The COVID-19 pandemic has been validated to have pretty destructive outcomes for the global market, as increasingly more human beings have followed the stay-at-home policy, which has decreased the call for top products. In addition, governments throughout the globe have taken measures that include enforcing lockdowns, which has altered the rise of the blood gas and electrolyte analyzer market.
Increasing occurrence of Chronic diseases and Technological Development in Blood Gas and Electrolyte Analyzer.